Speaker

Alison Burkart

Director, Analytical Development, Astellas Pharma

Alison Burkart, Director, Analytical Development at Astellas Pharma, is speaking at 3rd Raw Materials for Cell & Gene Therapy Summit (San Diego, United States of America, 26–28 Oct 2026) in the session “Planning Material Grade Transitions Early to Avoid Late-Stage Requalification & Delayed Timelines”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

3rd Raw Materials for Cell & Gene Therapy Summit
26–28 Oct 2026San Diego, United States of America
- WorkshopPlanning Material Grade Transitions Early to Avoid Late-Stage Requalification & Delayed Timelines

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Alison Burkart, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].